1
|
Bonnet D and Dick JE: Human acute myeloid
leukemia is organized as a hierarchy that originates from a
primitive hematopoietic cell. Nat Med. 3:730–737. 1997. View Article : Google Scholar : PubMed/NCBI
|
2
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
3
|
Liu J, Jiang Z, Xiao J, et al: Effects of
triptolide from Tripterygium wilfordii on ERalpha and p53
expression in two human breast cancer cell lines. Phytomedicine.
16:1006–1013. 2009.
|
4
|
Lu L, Kanwar J, Schmitt S, et al:
Inhibition of tumor cellular proteasome activity by triptolide
extracted from the Chinese medicinal plant ‘thunder god vine’.
Anticancer Res. 31:1–10. 2011.PubMed/NCBI
|
5
|
Yang S, Chen J, Guo Z, et al: Triptolide
inhibits the growth and metastasis of solid tumors. Mol Cancer
Ther. 2:65–72. 2003.PubMed/NCBI
|
6
|
Pigneux A, Mahon FX, Uhalde M, et al:
Triptolide cooperates with chemotherapy to induce apoptosis in
acute myeloid leukemia cells. Exp Hematol. 36:1648–1659. 2008.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Zhou Y, Xu Q and Huang Y: An in vitro
study of Triptolide inhibiting proliferation of vascular
endothelial cells. Practical J China. 6:564–566. 2004.
|
8
|
Lou YJ, Jin J and Wang YG: Triptolide
inhibits transcription factor NF-kappaB and induces apoptosis of
multiple myeloma cells. Leuk Res. 29:99–105. 2005. View Article : Google Scholar : PubMed/NCBI
|
9
|
Alvi AJ, Clayton H, Joshi C, et al:
Functional and molecular characterisation of mammary side
population cells. Breast Cancer Res. 5:R1–R8. 2003. View Article : Google Scholar : PubMed/NCBI
|
10
|
Chen Y and Rittling SR: Novel murine
mammary epithelial cell lines that form osteolytic bone metastases:
effect of strain background on tumor homing. Clin Exp Metastasis.
20:111–120. 2003. View Article : Google Scholar : PubMed/NCBI
|
11
|
Moltzahn FR, Volkmer JP, Rottke D and
Ackermann R: ‘Cancer stem cells’ - lessons from Hercules to fight
the Hydra. Urol Oncol. 26:581–589. 2008.
|
12
|
Liu S, Dontu G and Wicha MS: Mammary stem
cells, self-renewal pathways and carcinogenesis. Breast Cancer Res.
7:86–95. 2005. View
Article : Google Scholar : PubMed/NCBI
|
13
|
Abraham BK, Fritz P, McClellan M,
Hauptvogel P, Athelogou M and Brauch H: Prevalence of
CD44+/CD24−/low cells in breast cancer may
not be associated with clinical outcome but may favor distant
metastasis. Clin Cancer Res. 11:1154–1159. 2005.PubMed/NCBI
|
14
|
Ling LJ, Wang S, Liu XA, et al: A novel
mouse model of human breast cancer stem-like cells with high
CD44+CD24−/lower phenotype metastasis to
human bone. Chin Med J. 121:1980–1986. 2008.PubMed/NCBI
|
15
|
Ponti D, Costa A, Zaffaroni N, et al:
Isolation and in vitro propagation of tumorigenic breast cancer
cells with stem/progenitor cell properties. Cancer Res.
65:5506–5511. 2005. View Article : Google Scholar : PubMed/NCBI
|
16
|
Ginestier C, Hur MH, Charafe-Jauffret E,
et al: ALDH1 is a marker of normal and malignant human mammary stem
cells and a predictor of poor clinical outcome. Cell Stem Cell.
1:555–567. 2007. View Article : Google Scholar : PubMed/NCBI
|
17
|
Fan M, Yan PS, Hartman-Frey C, et al:
Diverse gene expression and DNA methylation profiles correlate with
differential adaptation of breast cancer cells to the antiestrogens
tamoxifen and fulvestrant. Cancer Res. 66:11954–11966. 2006.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Eriksson M, Guse K, Bauerschmitz G, et al:
Oncolytic adenoviruses kill breast cancer initiating
CD44+CD24−/low cells. Mol Ther. 15:2088–2093.
2007. View Article : Google Scholar : PubMed/NCBI
|
19
|
Qiu D and Kao PN: Immunosuppressive and
anti-inflammatory mechanisms of triptolide, the principal active
diterpenoid from the Chinese medicinal herb Tripterygium
wilfordii Hook. f. Drugs R D. 4:1–18. 2003. View Article : Google Scholar : PubMed/NCBI
|
20
|
Yang S, Chen J, Guo Z, et al: Triptolide
inhibits the growth and metastasis of solid tumors. Mol Cancer
Ther. 2:65–72. 2003.PubMed/NCBI
|
21
|
Frese S, Pirnia F, Miescher D, et al:
PG490-mediated sensitization of lung cancer cells to
Apo2L/TRAIL-induced apoptosis requires activation of ERK2.
Oncogene. 22:5427–5435. 2003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Zhang P, Zhang R and Wang Y: Research
progress on the antitumor molecular mechanism of triptolide. Acta
Chin Med Pharmacol. 3:79–82. 2009.(In Chinese).
|